INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 155 filers reported holding INARI MED INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $156,846,269 | +17.0% | 2,398,261 | +4.0% | 0.07% | +21.8% |
| Q2 2023 | $134,022,642 | +5.5% | 2,305,171 | +12.0% | 0.06% | +1.9% |
| Q1 2023 | $127,047,461 | -8.5% | 2,057,782 | -5.8% | 0.05% | -12.9% |
| Q4 2022 | $138,794,256 | -12.4% | 2,183,673 | +0.2% | 0.06% | -19.5% |
| Q3 2022 | $158,368,000 | -11.1% | 2,180,170 | -16.8% | 0.08% | -4.9% |
| Q2 2022 | $178,177,000 | -31.4% | 2,620,638 | -8.5% | 0.08% | -19.0% |
| Q1 2022 | $259,693,000 | +2.5% | 2,865,100 | +3.2% | 0.10% | +11.1% |
| Q4 2021 | $253,482,000 | +31.9% | 2,777,274 | +17.2% | 0.09% | +18.4% |
| Q3 2021 | $192,197,000 | -8.3% | 2,369,874 | +5.4% | 0.08% | -9.5% |
| Q2 2021 | $209,675,000 | -3.8% | 2,247,799 | +10.3% | 0.08% | -12.5% |
| Q1 2021 | $217,998,000 | +54.8% | 2,037,365 | +26.2% | 0.10% | +45.5% |
| Q4 2020 | $140,871,000 | +52.5% | 1,613,825 | +20.6% | 0.07% | +32.0% |
| Q3 2020 | $92,353,000 | +103.4% | 1,338,068 | +42.7% | 0.05% | +85.2% |
| Q2 2020 | $45,409,000 | – | 937,419 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darsana Capital Partners LP | 1,475,000 | $137,588,000 | 3.91% |
| Affinity Asset Advisors, LLC | 85,000 | $7,929,000 | 2.84% |
| Parian Global Management LP | 49,800 | $4,645,000 | 1.99% |
| AlpInvest Partners B.V. | 27,960 | $2,608,000 | 1.28% |
| Sio Capital Management, LLC | 46,332 | $4,322,000 | 1.07% |
| HARBOURVEST PARTNERS LLC | 88,598 | $8,264,000 | 0.79% |
| HAMILTON LANE ADVISORS LLC | 26,403 | $2,463,000 | 0.77% |
| Pier Capital, LLC | 76,708 | $7,155,000 | 0.72% |
| Lisanti Capital Growth, LLC | 46,035 | $4,294,000 | 0.53% |
| NEXT CENTURY GROWTH INVESTORS LLC | 66,822 | $6,233,000 | 0.49% |